| Q36858853 | "Know Hepatitis B:" A Multilingual Communications Campaign Promoting Testing for Hepatitis B Among Asian Americans and Pacific Islanders |
| Q27346723 | AACR Cancer Progress Report 2014 |
| Q30746254 | Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer |
| Q26781962 | Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection |
| Q59351316 | Beasley's 1981 paper: The power of a well-designed cohort study to drive liver cancer research and prevention |
| Q99568817 | Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019 |
| Q40194260 | Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B. |
| Q38797618 | Chronic hepatitis B and C infection in the United States: a review of current guidelines, disease burden and cost effectiveness of screening |
| Q92502172 | Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy |
| Q58077971 | Disparities in Hepatitis B Virus Infection and Immunity Among New York City Asian American Patients, 1997 to 2017 |
| Q64136724 | Electronic Medical Alerts Increase Screening for Chronic Hepatitis B: A Randomized, Double-Blind, Controlled Trial |
| Q90707949 | Healthcare Disparities Identified Between Hmong and Other Asian Origin Groups Living with Chronic Hepatitis B Infection in Sacramento County 2014-2017 |
| Q41685142 | Hepatitis B Screening in Asian and Pacific Islanders: New Guidelines, Old Barriers |
| Q91706568 | Hepatitis B Virus Reactivation in the Setting of Immunosuppressive Drug Therapy |
| Q35771194 | Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update. |
| Q91599709 | Hepatitis B: Screening, Awareness, and the Need to Treat |
| Q35108552 | Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review |
| Q38846376 | Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis. |
| Q36129764 | Lay Health Worker Intervention Improved Compliance with Hepatitis B Vaccination in Asian Americans: Randomized Controlled Trial. |
| Q35716226 | Medical training fails to prepare providers to care for patients with chronic hepatitis B infection |
| Q49981769 | Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study |
| Q26797207 | Molecular cancer prevention: Current status and future directions |
| Q35429416 | Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening |
| Q64118358 | Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices |
| Q38688782 | Prevention and management of hepatitis B virus reactivation in cancer patients |
| Q40464667 | Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers. |
| Q33872389 | Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg? |
| Q59351720 | Self-reported patient history to assess hepatitis B virus serological status during a large screening campaign |
| Q36858828 | Strategies for Expanding Access to HBV and HCV Testing and Care in the United States: The CDC Hepatitis Testing and Linkage to Care Initiative, 2012-2014 |
| Q36858844 | Testing and Linking Foreign-Born People with Chronic Hepatitis B Virus Infection to Care at Nine U.S. Programs, 2012-2014. |
| Q58773342 | The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review |
| Q36479996 | The distribution of hepatitis B virus exposure and infection in a population-based sample of U.S. Hispanic adults |
| Q59352054 | The prevalence of undetectable vaccine-induced immunity against hepatitis B virus in US adults at high risk for infection |
| Q64135444 | Trends in liver cancer mortality in the United States: Dual burden among foreign- and US-born persons |
| Q91964365 | Utility of oral fluid samples for hepatitis B antibody detection in real life conditions |
| Q36909250 | Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration |